Lindsay Goldberg - Private Equity Firm Profile | CT Acquisitions Directory - CT Acquisitions

Firm at a glance

Lindsay Goldberg is a platform private equity firm founded in 2001 and headquartered in New York, NY, per its own website [S1].

What they buy

The firm’s portfolio reflects a focus on three primary sectors: industrials, healthcare, and services [S2]. Observed investments span chemical distribution, food manufacturing, engineering services, dental and veterinary healthcare, mental health providers, and specialty manufacturing [S2]. Lindsay Goldberg appears to pursue platform acquisitions rather than add-on strategies, with approximately 22 platform companies identified across its current portfolio as of January 2026 [S2].

Portfolio

Healthcare

Platform investments include Lightwave Dental (acquired July 2023), MMS (acquired June 2022), Reign Research Holdings, Doppler Veterinary Network, Sero Mental Health, PT Solutions, Women’s Care Enterprises, Refresh Mental Health, and Second Spring Healthcare [S2].

Industrials

Platform investments include EMCO Chemical Distributors (acquired November 2025), Golden State Foods (acquired August 2024), Summit Interconnect (acquired September 2021), Aspire Bakeries (acquired March 2021), Liveo Research, Creation Technologies, Big Ass Fans, and Golden West Packaging Group [S2].

Services

Platform investments include Kleinfelder (acquired September 2023), Dash Car Wash, Amentum, stayAPT Suites, and Dealer Tire [S2].

Recent activity (last 24 months)

* January 2026: Closed Fund VI [S3]
* December 2025: Exited Pike Corporation [S3]
* November 2025: Acquired EMCO Chemical Distributors [S3]
* July 2025: Exited Liquid Tech Solutions [S3]
* April 2025: Completed add-on acquisition of Veenstra & Kimm [S3]
* August 2024: Acquired Golden State Foods [S3]
* July 2024: Exited Stelco [S3]

How this firm fits a seller

Lindsay Goldberg reported approximately $24 billion in committed capital as of December 2025 [S4], suggesting capacity for middle-market and larger platform transactions. The firm’s recent activity demonstrates both acquisition and exit capability, with two platform acquisitions and three exits completed in the trailing 24 months [S3]. The portfolio composition indicates potential fit for owner-operators in healthcare services, specialty manufacturing, and business services sectors where the firm has demonstrated repeat investment activity [S2]. Businesses in engineering services, chemical distribution, food manufacturing, or healthcare provider segments align with observed investment patterns [S2].

Sources

[S1] https://www.lindsaygoldbergllc.com (as of 2026-01-15)
[S2] https://www.lindsaygoldbergllc.com/companies (as of 2026-01-15)
[S3] https://www.lindsaygoldbergllc.com/news (as of 2026-01-06)
[S4] https://www.lindsaygoldbergllc.com/about (as of 2025-12-31)

Frequently asked questions

Does Lindsay Goldberg buy healthcare businesses?

Yes, healthcare represents a substantial portion of the firm’s portfolio, with approximately nine healthcare platform companies identified as of January 2026 [S2]. Observed healthcare investments span dental services, veterinary care, mental health providers, physical therapy, and women’s health [S2].

What companies has Lindsay Goldberg acquired recently?

Recent platform acquisitions include EMCO Chemical Distributors in November 2025 and Golden State Foods in August 2024 [S3]. The firm also completed an add-on acquisition of Veenstra & Kimm in April 2025 [S3].

Where is Lindsay Goldberg based and how big is the firm?

The firm operates from New York, NY [S1]. Lindsay Goldberg reported approximately $24 billion in committed capital as of December 2025 and closed Fund VI in January 2026 [S4][S3].

Is Lindsay Goldberg still actively acquiring?

Yes, the firm completed its most recent platform acquisition in November 2025 with EMCO Chemical Distributors and closed a new fund in January 2026 [S3], indicating active investment activity.

This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.